当前位置：
X-MOL 学术
›
Leuk. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy.
Leukemia Research ( IF 2.1 ) Pub Date : 2021-06-10 , DOI: 10.1016/j.leukres.2021.106640 Anthony M Hunter 1 , Najla Al Ali 2 , Anne Mai 3 , Savan Shah 4 , David M Swoboda 4 , Andrew Kuykendall 2 , Chetasi Talati 2 , Kendra L Sweet 2 , David A Sallman 2 , Jeffrey E Lancet 2 , Rami S Komrokji 2 , Eric Padron 2
中文翻译：
白细胞增多症与慢性粒单核细胞白血病的终末器官损伤和死亡率有关，可以通过细胞减灭疗法减轻。
更新日期：2021-06-10
Leukemia Research ( IF 2.1 ) Pub Date : 2021-06-10 , DOI: 10.1016/j.leukres.2021.106640 Anthony M Hunter 1 , Najla Al Ali 2 , Anne Mai 3 , Savan Shah 4 , David M Swoboda 4 , Andrew Kuykendall 2 , Chetasi Talati 2 , Kendra L Sweet 2 , David A Sallman 2 , Jeffrey E Lancet 2 , Rami S Komrokji 2 , Eric Padron 2
Affiliation
中文翻译：
白细胞增多症与慢性粒单核细胞白血病的终末器官损伤和死亡率有关，可以通过细胞减灭疗法减轻。
京公网安备 11010802027423号